New York, NY – 2026-08-18 · Ticker: NYSE:MDT
Signal Proxy Intelligence Recommends AGAINST on Renewal of the Board’s Authority to Opt Out of Statutory Pre-Emption Rights Under Irish Law at Medtronic plc Ahead of Oct. 15, 2026 Annual Meeting
Independent research firm publishes item-by-item recommendations on all 17 ballot measures within 27 hours of the company’s proxy filing. (Within SPI’s standing 48-hour / T+2 commitment.)
NEW YORK, NY — Signal Proxy Intelligence, the independent proxy research division of Signal Law Group, today published its recommendations for the Oct. 15, 2026 annual meeting of Medtronic plc (NYSE:MDT). SPI issued a recommendation on each of the 17 items on the ballot, published 27 hours after the company’s definitive proxy statement was accepted on EDGAR.
Reviewing the ballot from the perspective of the common shareholder and using publicly available information only, SPI assigned the meeting a concern band of Elevated. The firm recommends FOR on the advisory vote on executive compensation, citing that shareholders approved named executive officer compensation by 93.45% of votes cast at the 2025 annual meeting.
On the election of directors, SPI recommends FOR all 12 director nominees.
“This ballot included one item where our recommendation diverged from the board’s under our published framework. The meeting carries a concern band of Elevated, and the full rationale for each recommendation is documented in the report.”
— Hayden Smith, Head of Proxy Research
SPI recommends AGAINST on the following item:
- AGAINST on Item 5 (Renewal of the Board’s Authority to Opt Out of Statutory Pre-Emption Rights Under Irish Law): Without this authorization, existing shareholders would first have to be offered shares on a pro-rata basis.
SPI will publish a separate post-meeting divergence report comparing its recommendations to those of the incumbent proxy advisors after the meeting results are available.
The complete item-by-item analysis, including the rationale for each recommendation, is available at https://www.signallawgroup.com/proxies/medtronic-plc-2026-10-15/.
Ballot Summary: Recommendation by Item
| Item | Title | SPI Recommendation |
|---|---|---|
| 1a | Election of Craig Arnold | FOR |
| 1b | Election of Scott C. Donnelly | FOR |
| 1c | Election of Lidia L. Fonseca | FOR |
| 1d | Election of John P. Groetelaars | FOR |
| 1e | Election of Randall J. Hogan, III | FOR |
| 1f | Election of William R. Jellison | FOR |
| 1g | Election of Joon S. Lee, M.D. | FOR |
| 1h | Election of Gregory P. Lewis | FOR |
| 1i | Election of Kevin E. Lofton | FOR |
| 1j | Election of Geoffrey (Geoff) Martha | FOR |
| 1k | Election of Elizabeth G. Nabel, M.D. | FOR |
| 1l | Election of Kendall J. Powell | FOR |
| 2 | Non-Binding Ratification of Appointment of Independent Auditor and Binding Authorization of the Board of Directors, Acting Through the Audit Committee, to Set Auditor Remuneration | FOR |
| 3 | Advisory Resolution to Approve Named Executive Officer Compensation (Say-on-Pay) | FOR |
| 4 | Renewal of the Board’s Authority to Issue Shares Under Irish Law | FOR |
| 5 | Renewal of the Board’s Authority to Opt Out of Statutory Pre-Emption Rights Under Irish Law | AGAINST |
| 6 | Authorization of the Company and Any Subsidiary of the Company to Make Overseas Market Purchases of Medtronic Ordinary Shares | FOR |
About Signal Proxy Intelligence
SPI is the independent proxy research division of Signal Law Group, an independent research and investigations firm. SPI publishes FOR / AGAINST / WITHHOLD recommendations on every item of every covered proxy ballot within 48 hours of filing, analyzing each measure from the perspective of the common shareholder using publicly available information. SPI accepts no revenue from the companies it covers. Every SPI recommendation is timestamped at publication, fingerprinted, and reconciled against the company’s reported vote.
Media contact
Rochelle Welner
contact@signallawgroup.com
# # #
SPI is an operating company of Signal Law Group, an independent research and investigations firm. SPI is not a law firm, does not provide legal advice, and is not an investment adviser. The recommendations and analysis in this release are independent research provided for informational purposes only. They do not constitute voting advice, investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. Recipients should conduct their own independent analysis and consult their own advisors before making any voting or investment decision. SPI accepts no revenue from the companies it covers.
